Manufacturing and Production

Showing 15 posts of 5879 posts found.

Olivier Brandicourt

Brandicourt sets out Sanofi’s long-term vision

November 6, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, olivier brandicourt, pharma strategy

Sanofi has pledged to plough the money saved from its business restructure into R&D investment, to bring 18 new products …
Pascale Witz Sanofi

Sanofi and Hanmi partner to create long-acting diabetes treatments

November 5, 2015 Manufacturing and Production, Research and Development Korea, Sanofi, diabetes, hanmi

Sanofi and Hanmi Pharmaceutical have announced a worldwide license agreement to develop a portfolio of experimental, long-acting diabetes treatments. Korea’s …
OECD logo

OECD report warns of high spend and slow growth for pharma industry

November 5, 2015 Manufacturing and Production, Sales and Marketing OECD, pharmaceutical spending

The high prices that pharma companies charge for specialty medicines are straining the health budgets of wealthy nations, according to …
President Obama

Obama government launches drug price crackdown

November 4, 2015 Manufacturing and Production, Research and Development, Sales and Marketing Drug pricing, President Obama, US, affordability, market access

President Obama has launched an ‘Affordable Drug Pricing Task Force’, aimed at tackling the spiralling cost of certain prescription medications …
Novo Nordisk building

Novo Nordisk invests in new insulin-filling facility

November 4, 2015 Manufacturing and Production Denmark, Novo Nordisk, manufacturing, production

Novo Nordisk is investing 2.1 billion Danish Kroner (about £200m) in a new facility in Hillerød, Denmark, which will produce diabetes …
paul_oliver_cfo_biocity

Pharma R&D hub BioCity appoints new CFO

November 3, 2015 Manufacturing and Production, Research and Development, Sales and Marketing BioCity, Paul Oliver

BioCity, the UK bioscience incubator, has appointed Paul Oliver as chief financial officer as it prepares to grow across its …

Sanofi claims $109m impact on revenue following recall

November 3, 2015 Manufacturing and Production Sanofi, finance, maufacturing, product recall

As Sanofi recalls its Auvi-Q epinephrine injection for the treatment of severe allergic reactions – after the company found the …
Europe Member State flags

EU plans export waiver for pharma manufacturing

November 3, 2015 Manufacturing and Production EGA, European Commission, biologics, biosimilars, generics, manufacturing, supplementary protection certificates

The European Commission plans to bring in an export waiver for supplementary protection certificates, in order to boost pharma industry …
R&D

Sanofi and BioNTech in cancer immunotherapy partnership

November 3, 2015 Manufacturing and Production, Research and Development BioNTech, Cancer, Sanofi, immunotherapy

Sanofi and BioNTech have agreed a new multi-year exclusive collaboration and license agreement, to discover and develop up to five …

Mylan appoints a global commercial lead for OTC business

November 3, 2015 Manufacturing and Production Mylan, OTC, Ranjan Ray Chaudhuri, over the counter

Mylan has appointed Ranjan Ray Chaudhuri as its new global commercial lead for the company’s over-the-counter (OTC) business. Chaudhuri will …
China manufacturing

FDA alleges records cover-up at Chinese Pfizer plant

November 3, 2015 Manufacturing and Production FDA, Pfizer, compliance, inspection, manufacturing, production, regulations

The FDA has discovered violations at a Pfizer plant in China, including the use of out-of-date materials and record- keeping …
3D printer

Featured market report: 3D printing market summary

November 2, 2015 Manufacturing and Production 3d printing, manufacturing, medical devices, production

The global 3D printing medical devices market is estimated to grow at a CAGR of 25.3% from 2015 to 2020.The …
Shire

Shire to acquire Dyax in $5.9 billion deal

November 2, 2015 Manufacturing and Production, Research and Development, Sales and Marketing Dyax, M&A, MA, R&D, Shire, hereditary angioedema, rare disease

Shire has struck a deal to acquire the biotech firm Dyax for $5.9 billion, in order to acquire exclusive rights …
neil_brewis_photo

Biopharma firm F-star appoints Dr Neil Brewis as CSO

November 2, 2015 Manufacturing and Production, Research and Development F-star, Neil Brewis

F-star, a biopharma company focused on immuno-oncology, has hired Dr Neil Brewis as chief scientific officer. Dr Brewis is a former vice …
sanofi_logo_vertical_2011_4colors-web

Sanofi recalls allergy injection pens

October 29, 2015 Manufacturing and Production Allerject, Sanofi, anaphylaxis

Sanofi has halted manufacturing and is recalling its Allerject auto-injectors following a blunder involving incorrect dosages. The voluntary recall involves …
The Gateway to Local Adoption Series

Latest content